Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia

Patients with B cell precursor acute lymphoblastic leukemia (BPL) respond well to chemotherapy at initial diagnosis; however, therapeutic options are limited for individuals with BPL who relapse. Almost all BPL cells express CD19, and we recently cloned the gene encoding a natural ligand of the huma...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Invest
Asıl Yazarlar: Uckun, Fatih M., Myers, Dorothea E., Qazi, Sanjive, Ozer, Zahide, Rose, Rebecca, D’Cruz, Osmond J., Ma, Hong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362237/
https://ncbi.nlm.nih.gov/pubmed/25621496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI76610
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller